Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The target compound was detected by multiple reaction monitoring in the positive electrospray ionization mode
Endocrinology, 112(5), 1613-1617
Everolimus plus exemestane for hormonereceptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Ginsenosides, the primary bioactive compounds in Panax ginseng , exert potent anti-inflammatory effects by suppressing proinflammatory cytokines and inhibiting signaling pathways such as NF-B
US$ 21.18
US$ 21.43
US$ 29.91
US$ 29.04
